Showing results (1-10 of 164) with videos related to
Sort By:
Pageof 17
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|February 13, 1999
[Dyslipidemias and autoimmune diseases]Z S Alekberova, V A NasonovaArchives of Virology|January 1, 1975
Molecular pathogenesis of systemic lupus erythematosusZ S Alekberova, M I Parfanovich, V A Nasonova, et al.Voprosy Virusologii|January 1, 1984
[Successful results in the interferon therapy of autoimmune disease in NZB/W strain mice]I F Barinskiĭ, Z S Alekberova, V A Savinov, et al.Terapevticheskii Arkhiv|January 1, 1997
[The late diagnosis of systemic lupus erythematosus with the antiphospholipid syndrome]V A Nasonova, Z S Alekberova, L A Kalashnikova, et al.Terapevticheskii Arkhiv|January 1, 1992
[The clinico-immunological subtypes of systemic lupus erythematosus]A I Speranskiĭ, V A Nasonova, S M Ivanova, et al.Terapevticheskii Arkhiv|January 1, 1988
[Rheumatoid arthritis with systemic manifestations: its diagnosis and clinical aspects]V A Nasonova, Z S Alekberova, R S Saĭkovskii, et al.Klinicheskaia Meditsina|January 15, 2000
[Thrombo ASS in the prophylaxis of vascular disorders in antiphospholipid syndrome]T M Reshetniak, E S Mach, E N Aleksandrova, et al.Klinicheskaia Meditsina|June 1, 1990
[Clinico-immunological characteristics of patients with rheumatoid arthritis and symptoms of cutaneous vasculitis (cooperative Soviet-Polish study)]V A Nasonova, Z S Alekberova, R M Balabanova, et al.Terapevticheskii Arkhiv|July 10, 2003
[Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up]T M Reshetniak, Z S Alekberova, G P Kotel'nikova, et al.Pageof 17